TY - JOUR
T1 - Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score
AU - Schmidt, Matthieu
AU - Bailey, Michael John
AU - Sheldrake, Jayne
AU - Hodgson, Carol Lynette
AU - Aubron, Cecile
AU - Rycus, Peter T
AU - Scheinkestel, Carlos
AU - Cooper, David James
AU - Brodie, Daniel
AU - Pellegrino, Vincent
AU - Combes, Alain
AU - Pilcher, David V
PY - 2014
Y1 - 2014
N2 - Rationale: Increasing use of extracorporeal membrane oxygenation (ECMO) for acute respiratory failure may increase resource requirements and hospital costs. Better prediction of survival in these patients may improve resource utilisation, allow risk-adjusted comparison of center-specific outcomes and help clinicians to target patients most likely to benefit from ECMO. Objectives: To create a model for predicting hospital survival at initiation of ECMO for respiratory failure. Methods: Adult patients with severe acute respiratory failure treated by ECMO from 2000 to 2012 were extracted from the Extracorporeal Life Support Organization (ELSO) international registry. Multivariable logistic regression was used to create the Respiratory ECMO Survival Prediction score (RESP-score) using bootstrapping methodology with internal and external validation. Main results: Of the 2355 patients included in the study, 1338 patients (57 ) were discharged alive from hospital. The RESP-score was developed using pre-ECMO variables independently associated with hospital survival on logistic regression which included: age, immunocompromised status, duration of mechanical ventilation prior to ECMO, diagnosis, central nervous system dysfunction, acute associated non-pulmonary infection, neuro-muscular blockade agents or nitric oxide use, bicarbonate infusion, cardiac arrest, PaCO2 and peak inspiratory pressure. The ROC curve analysis of the RESP score was c=0.74, 95 Confidence Interval (0.72 ? 0.76). External validation, performed on 140 patients, exhibited excellent discrimination (c=0.92 [95 CI 0.89 ? 0.97]). Conclusions: The RESP-score is a relevant and validated tool to predict survival for patients receiving ECMO for respiratory failure.
Read More: http://www.atsjournals.org/doi/abs/10.1164/rccm.201311-2023OC?url_ver=Z39.88-2003 rfr_id=ori:rid:crossref.org rfr_dat=cr_pub 3dpubmed .U36zm51--70
AB - Rationale: Increasing use of extracorporeal membrane oxygenation (ECMO) for acute respiratory failure may increase resource requirements and hospital costs. Better prediction of survival in these patients may improve resource utilisation, allow risk-adjusted comparison of center-specific outcomes and help clinicians to target patients most likely to benefit from ECMO. Objectives: To create a model for predicting hospital survival at initiation of ECMO for respiratory failure. Methods: Adult patients with severe acute respiratory failure treated by ECMO from 2000 to 2012 were extracted from the Extracorporeal Life Support Organization (ELSO) international registry. Multivariable logistic regression was used to create the Respiratory ECMO Survival Prediction score (RESP-score) using bootstrapping methodology with internal and external validation. Main results: Of the 2355 patients included in the study, 1338 patients (57 ) were discharged alive from hospital. The RESP-score was developed using pre-ECMO variables independently associated with hospital survival on logistic regression which included: age, immunocompromised status, duration of mechanical ventilation prior to ECMO, diagnosis, central nervous system dysfunction, acute associated non-pulmonary infection, neuro-muscular blockade agents or nitric oxide use, bicarbonate infusion, cardiac arrest, PaCO2 and peak inspiratory pressure. The ROC curve analysis of the RESP score was c=0.74, 95 Confidence Interval (0.72 ? 0.76). External validation, performed on 140 patients, exhibited excellent discrimination (c=0.92 [95 CI 0.89 ? 0.97]). Conclusions: The RESP-score is a relevant and validated tool to predict survival for patients receiving ECMO for respiratory failure.
Read More: http://www.atsjournals.org/doi/abs/10.1164/rccm.201311-2023OC?url_ver=Z39.88-2003 rfr_id=ori:rid:crossref.org rfr_dat=cr_pub 3dpubmed .U36zm51--70
UR - http://www.atsjournals.org/doi/pdf/10.1164/rccm.201311-2023OC
U2 - 10.1164/rccm.201311-2023OC
DO - 10.1164/rccm.201311-2023OC
M3 - Article
VL - 189
SP - 1374
EP - 1382
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
SN - 1073-449X
IS - 11
ER -